Tag

    The Food and Drug Administration has projected a March deadline to release its long-awaited review of the safety of the abortion pill. A court document says the FDA “plans to compare mifepristone’s safety to that of surgical abortions through 10 weeks’ gestation,”... Read More →

    In an unsurprising move, the FDA announced Thursday that it has officially approved the Opill, a progestin-only birth control pill, for over-the-counter use (OTC) for all women of reproductive age. It will be the first hormonal birth control pill ever to be sold... Read More →